Controversy / subject hub

Fda

Sourced Donald Trump records grouped under fda. This page is an index: the full evidence, photo credits, videos and source ledger remain attached to the dated canonical record.

September 14, 2026 · FDA / Psychedelic drugs / Therapeutic development / Public hearing

FDA holds public hearing on potential future therapeutic use of psychedelic drugs

FEDERAL PUBLIC HEARING — FDA TOOK INPUT ON POTENTIAL FUTURE THERAPEUTIC USE IN SUPERVISED SETTINGS; THE HEARING DID NOT APPROVE A DRUG, LEGALIZE PSYCHEDELICS OR CHANGE CONTROLLED-SUBSTANCE SCHEDULING

The FDA held a September 14 public hearing with federal partners to gather input on the potential future therapeutic use of drug products containing psychedelic substances in supervised and supportive settings. Reuters described the hearing as part of a broader Trump-administration effort to accelerate development of psychedelic therapies for serious mental-health conditions. The hearing itself was an information-gathering proceeding: it did not approve a specific product, legalize psychedelic use, or change federal controlled-substance scheduling.

Open the full dated evidence record →

Back to August 2026 archive